Related Experiment Video
Updated: Feb 7, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.5K
Should omalizumab be used in severe asthma/COPD overlap?
B Sposato1, M Scalese2, M Milanese3
1Pneumology Department, Misericordia Hospital, Grosseto, Italy.
Journal of Biological Regulators and Homeostatic Agents
|July 26, 2018
Summary
Omalizumab may help severe asthma-COPD overlap (ACO) patients unresponsive to standard treatments. While effective, its benefits in ACO might be less pronounced than in severe asthma alone.
Area of Science:
- Respiratory Medicine
- Immunology
Background:
- Asthma-COPD overlap (ACO) presents complex challenges, with severe cases often resistant to triple therapy.
- Investigating omalizumab's efficacy in poorly controlled, severe ACO is crucial for advancing treatment strategies.
Discussion:
- Omalizumab, targeting IgE, may ameliorate eosinophilic inflammation in ACO, a key component of the asthma phenotype.
- Treatment response may depend on underlying inflammatory pathways (Th2 vs. Th1/Th17) and biomarkers like IgE, FeNO, and eosinophil counts.
Key Insights:
- Limited studies suggest omalizumab can improve asthma-related outcomes in severe ACO.
- The effectiveness of omalizumab in ACO may be less than in severe asthma alone, necessitating careful patient selection.
Outlook:
- Further research is needed to fully elucidate omalizumab's role and optimize its use in severe ACO.
- Identifying predictive biomarkers could personalize omalizumab therapy for ACO patients, improving treatment outcomes.
Related Concept Videos
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
COPD: Management Using Bronchodilators and Corticosteroids
820
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
820
¹H NMR: Interpreting Distorted and Overlapping Signals
1.5K
Spin systems where the difference in chemical shifts of the coupled nuclei is greater than ten times J are called first-order spin systems. These nuclei are weakly coupled, and their chemical shifts and coupling constant can generally be estimated from the well-separated signals in the spectrum.
As Δν decreases and the signals move closer, the doublets appear increasingly distorted. The intensities of the inner lines increase at the cost of those of the outer lines as the signals are...
As Δν decreases and the signals move closer, the doublets appear increasingly distorted. The intensities of the inner lines increase at the cost of those of the outer lines as the signals are...
1.5K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K

